Cargando…

Dabrafenib- and trametinib-associated glomerular toxicity: A case report

RATIONALE: Combined treatment with dabrafenib, a B-RAF inhibitor, and trametinib, a mitogen-activated protein kinase inhibitor, is an effective option for patients with metastatic melanoma. A few cases of acute kidney injury associated with tubulointerstitial nephritis and 1 case of nephrotic syndro...

Descripción completa

Detalles Bibliográficos
Autores principales: Jo, Eunmi, Rhee, Harin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8735797/
https://www.ncbi.nlm.nih.gov/pubmed/35029901
http://dx.doi.org/10.1097/MD.0000000000028485

Ejemplares similares